Molecular and biochemical pharmacology of mitoxantrone

Cancer Treatment Reviews
|December 1, 1983
PubMed

Insights

Nv, a novel compound, damages DNA by crosslinking and breaking strands, inhibiting synthesis, and causing cell cycle arrest. Resistance may develop due to impaired drug transport.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Understanding novel anti-cancer agents is crucial for therapeutic development.
  • The mechanism of action for many DNA-targeting drugs requires further elucidation.

Purpose of the Study:

  • To investigate the DNA interaction and cellular effects of Nv.
  • To determine the potential cardiotoxicity and resistance mechanisms of Nv.

Main Methods:

  • DNA intercalation and crosslinking assays.
  • Inhibition studies on DNA and RNA synthesis.
  • Cell cycle analysis and cytotoxicity assays.
  • In vitro resistance induction and drug transport studies.

Main Results:

  • Nv intercalates into DNA, preferentially at G-C base pairs, causing single and double-strand breaks.
  • It inhibits DNA and RNA synthesis, induces nuclear aberrations, and blocks cells in the G2 phase.
  • Nv does not induce free radicals or lipid peroxidation; it may inhibit ADR-stimulated peroxidation.
  • Resistance to Nv in vitro is linked to impaired drug transport via cell membrane alterations.

Conclusions:

  • Nv exerts anti-tumor effects primarily through DNA damage and inhibition of nucleic acid synthesis.
  • Its mechanism involves chromosomal interaction and DNA damage, leading to cell death.
  • Nv shows a low potential for cardiotoxicity and can induce cellular resistance through transport inhibition.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...